surfac
plasmon
reson
spr
appear
revolutionari
technolog
almost
year
ago
first
commerci
instrument
launch
market
pharmacia
biosensor
ab
swedish
compani
deriv
pharmacia
ab
compani
develop
innov
technolog
joint
effort
physicist
chemist
biologist
engin
comput
scientist
sinc
mani
scientist
join
spr
test
new
applic
variou
analyt
field
food
safeti
eg
mycotoxin
genet
modifi
organ
gmo
microbi
contamin
escherichia
coli
dope
analysi
laboratori
medicin
proteom
bacteria
detect
also
environment
monitor
among
assuredli
clinic
analysi
also
explor
fruit
applic
field
advantag
brought
current
spr
technolog
includ
realtim
monitor
analytemolecular
marker
label
free
parallel
analysi
spri
minim
sampl
pretreat
quantit
respons
good
sensit
reproduc
report
detect
limit
atto
femtomolar
rang
coeffici
variat
featur
coupl
miniatur
make
spr
suitabl
point
care
poc
diagnost
fast
analysi
multianalyt
detect
mandatori
review
focus
analysi
target
interest
molecular
diagnost
complex
real
matric
eg
serum
saliva
blood
urin
also
standard
solut
detect
strategi
innov
involv
improv
analyt
perform
panel
revis
analyt
includ
hormon
steroid
peptid
protein
clinic
marker
antibodi
involv
immun
disord
nucleic
acid
genet
diseas
clinic
marker
ie
mirna
bacteri
cell
virus
pathogen
detect
far
research
articl
come
academ
exercis
confid
applic
spr
clinic
medic
analysi
gain
momentum
next
futur
physic
principl
state
art
surfac
plasmon
reson
surfac
plasmon
reson
imagingbas
biosensor
review
mani
excel
work
begin
centuri
wood
first
scientist
describ
inhomogen
distribut
light
diffract
grate
spectrum
caus
surfac
plasmon
wave
spw
sixtysix
year
later
kretschmann
otto
rigor
demonstr
optic
excit
surfac
plasmon
sp
method
attenu
total
reflect
atr
spr
defin
chargedens
oscil
interfac
two
media
dielectr
constant
opposit
sign
eg
metal
dielectr
gener
surfac
plasmon
wave
spw
propag
constant
express
follow
equat
documentclass
minim
usepackag
amsmath
usepackag
wasysym
usepackag
amsfont
usepackag
amssymb
usepackag
amsbsi
usepackag
mathrsf
usepackag
upgreek
setlength
oddsidemargin
begin
document
beta
frac
omega
c
sqrt
frac
varepsilonm
varepsilon
varepsilonm
varepsilon
end
document
angular
frequenc
c
speed
light
vacuum
dielectr
constant
dielectr
metal
respect
metaldielectr
interfac
electromagnet
field
spw
maximum
intens
exponenti
decreas
evanesc
wave
ew
media
variabl
penetr
nm
vi
nir
wavelength
prism
coupler
grate
coupler
metaldielectr
waveguid
configur
use
excit
surfac
plasmon
first
one
repres
common
approach
plasmon
excit
via
attenu
total
reflect
method
atr
kretschmann
geometri
becom
also
suitabl
sens
biosens
applic
kretschmann
geometri
light
wave
total
reflect
boundari
thin
metal
layer
typic
gold
silver
nm
thick
high
refract
prism
coupler
typic
glass
reflect
light
excit
surfac
plasmon
metal
film
gener
ew
spw
penetr
metal
layer
fig
spr
base
biosensor
belong
refractometr
devic
sinc
propag
spw
sensit
chang
refract
index
dielectr
bind
analyt
bioreceptor
immobil
sens
surfac
caus
local
chang
refract
index
fig
variat
propag
constant
gener
real
time
signal
labelfre
way
sinc
label
ad
solut
develop
analyt
signal
classic
spr
spectroscopi
base
monitor
coupl
angl
coupl
wavelength
intens
phase
wherea
spr
imag
spri
base
measur
reflect
monochromat
incid
light
fix
angl
mean
ccd
camera
compar
tradit
spr
spri
offer
main
breakthrough
multiplex
detect
design
pattern
microarray
molecular
probe
realtim
visual
whole
biochip
surfac
monitor
simultan
multipl
bioreceptoranalyt
bind
parallel
support
digit
imag
repres
intens
bind
color
scale
side
spri
suffer
order
magnitud
wors
resolut
classic
spr
versu
riu
biosensor
select
depend
bioreceptor
immobil
sens
surfac
present
discuss
work
appear
last
year
aim
develop
robust
reliabl
spr
assay
clinic
diagnost
among
bioreceptor
enumer
antibodi
nucleic
acid
probe
synthet
receptor
molecular
imprint
polym
mip
aptam
artifici
dna
xna
accordingli
customari
talk
immunosensor
nucleic
acid
sensor
aptasensor
immunosensor
use
affin
interact
antigen
antibodi
nucleic
acid
na
sensor
base
oligonucleotid
probe
na
hybrid
reaction
na
sensor
artifici
nucleosid
xna
oligom
also
employ
bioreceptor
clinic
applic
xna
increas
sensor
stabil
avoid
biodegrad
exploit
improv
affin
xna
versu
target
sequenc
compar
convent
dna
probe
agata
et
al
review
work
deal
great
potenti
artifici
dna
pna
lna
hna
morf
nucleic
acid
sprbase
sens
exhibit
higher
select
sensit
detect
complementari
mismatch
nucleic
acid
target
behind
aptasensor
emerg
last
year
interest
altern
immunosens
aptam
na
molecul
bind
predetermin
target
small
molecul
well
protein
peptid
high
affin
specif
nucleic
acid
aptam
engin
repeat
round
vitro
select
equival
systemat
evolut
ligand
exponenti
enrich
selex
final
mip
sensor
take
advantag
total
synthet
molecular
recognit
element
constitut
highli
crosslink
polym
engin
bind
one
target
compound
class
structur
relat
target
compound
high
select
interest
applic
clinic
diagnost
recent
report
synthet
receptor
xna
still
use
aptam
mip
instead
bioreceptor
first
immobil
sens
surfac
purpos
differ
approach
report
furthermor
suitabl
assay
format
appli
depend
clinic
applic
aspect
discuss
next
paragraph
sprbase
biosensor
develop
immobil
biomolecul
sens
surfac
key
step
essenti
success
analysi
particular
featur
consid
optim
bioreceptor
immobil
procedur
deal
retent
biolog
activ
analyt
immobil
compat
bind
activ
rang
analyt
detect
amount
immobil
bioreceptor
avoid
steric
hindranc
reproduc
immobil
assur
reproduc
result
final
regener
biosens
surfac
receptoranalyt
dissoci
without
compromis
biolog
activ
receptor
sensor
applic
real
matric
immobil
chemistri
optim
also
prevent
unspecif
interact
surfac
aris
matrix
compon
ie
protein
blood
serum
etc
bind
biomolecul
goldsens
surfac
achiev
mani
suitabl
immobil
approach
physic
absorpt
hydrophob
via
lipid
layer
electrostat
interact
coval
coupl
coupl
nucleophil
carboxyl
group
thiol
group
aldehyd
group
coupl
nativ
tag
molecul
avidinbiotin
among
last
two
approach
sure
exploit
clinic
diagnosi
applic
cheap
eas
realiz
stabil
robust
particular
nucleotid
effici
immobil
modif
thiol
group
exploit
high
affin
sulphur
gold
surfac
altern
biotin
label
via
affin
interact
avidin
streptavidin
coat
chip
surfac
strategi
format
selfassembl
monolay
sam
increas
degre
freedom
bioreceptor
consequ
bind
analyt
protein
eg
antibodi
peptid
wide
immobil
coval
amin
coupl
amino
group
protein
activ
nhsedc
solut
carboxyl
linker
alkanethiol
disulfid
sam
format
carboxymethyl
dextran
matrix
immobil
approach
rapid
simpl
inexpens
bring
random
orient
bioreceptor
attribut
multipl
function
group
protein
could
decreas
conform
flexibl
hinder
bioreceptorsanalyt
interact
thu
lower
sensor
sensit
altern
strategi
control
orient
instead
base
affin
reaction
biotinconjug
protein
strept
avidinco
chip
addit
interact
fc
protein
g
could
also
exploit
ab
immobil
prevent
nonspecif
adsorpt
biomolecul
eg
protein
spr
sens
surfac
anoth
keystep
develop
specif
biosensor
real
applic
clinic
diagnost
complex
matric
serum
blood
urin
analyz
strategi
frequent
adopt
fuction
surfac
nonfoul
materi
resist
nonspecif
interact
glycolderiv
oligopolym
oligo
ethylen
glycol
oeg
poli
ethylen
glycol
peg
also
poli
llysin
graft
poli
ethylen
glycol
pllgpeg
success
protect
nonspecif
interact
due
stericentrop
barrier
properti
coupl
high
degre
hydrat
peg
molecul
report
et
al
two
assay
format
direct
indirect
mostli
adopt
spr
biosensor
detect
analyt
clinic
diagnosi
scheme
fig
assay
select
base
mw
analyt
bioreceptorsanalyt
affin
matric
investig
direct
assay
bioreceptor
immobil
sens
surfac
analyt
ad
solut
affin
interact
caus
refract
index
variat
provid
analyt
signal
proport
analyt
concentr
strategi
usual
adopt
analyt
mw
greater
da
suffici
develop
refract
index
variat
result
detect
signal
moreov
multistep
direct
assay
fig
dl
lower
use
secondari
bioreceptor
specif
analyt
sandwich
format
label
secondari
bioreceptor
biomolecul
nanoparticl
often
employ
increas
assay
sensit
indirect
assay
prefer
low
mw
analyt
x
da
purifi
analyt
conjug
immobil
spr
surfac
specif
bioreceptor
incub
sampl
analyz
inject
sens
surfac
solut
reach
surfac
remain
free
bioreceptor
bind
immobil
analyt
provid
signal
invers
proport
concentr
sampl
besid
secondari
bioreceptor
label
ad
solut
improv
sensit
lower
dl
multistep
assay
recent
mani
develop
spr
technolog
perform
improv
sensor
analyt
perform
term
sensit
specif
detect
real
matrix
strategi
offer
nanoparticl
coupl
plasmon
sensor
miniatur
low
cost
system
gao
et
al
examin
recent
work
engin
hybrid
spr
interfac
oxidebas
hybrid
spr
interfac
nanocomposit
film
analyz
optic
properti
suitabl
applic
sens
recent
bedford
et
al
specif
review
recent
trend
incorpor
gnp
within
sens
surfac
tag
molecul
spr
biosensor
signific
sensit
increas
dl
decreas
describ
varieti
analyt
report
minunni
spoto
increas
sensit
explain
mass
enhanc
np
ew
well
optic
coupl
surfac
plasmon
sp
electr
field
local
surfac
plasmon
lsp
np
close
metal
surfac
lsp
defin
collect
electron
oscil
confin
mnp
surfac
promot
interact
light
mnp
dimens
much
smaller
wavelength
excit
light
local
electromagnet
field
strongli
enhanc
contribut
increas
sensit
also
expect
np
cluster
sinc
proven
cluster
spheric
metal
dielectr
colloid
show
strong
electr
magnet
fanolik
reson
electromagnet
coupl
close
space
particl
zanoli
et
al
review
employ
function
gold
nanoparticl
ultrasensit
dna
detect
differ
transduct
system
includ
spr
use
bypass
pcr
amplif
step
sinc
previous
defin
sprbase
biosensor
labelfre
system
sake
clariti
specifi
addit
bioreceptor
label
nanoparticl
employ
signal
develop
improv
system
analyt
perform
sensit
increas
dl
decreas
realli
essenti
clinic
diagnost
analyt
complex
matric
low
concentr
drawback
np
use
could
found
np
synthet
step
tune
dimens
absorpt
wavelength
coupl
plasmon
sinc
step
time
reagentconsum
furthermor
seem
constrict
employ
np
reusabl
sensor
sinc
surfac
poison
could
occur
compromis
serial
measur
chip
data
regener
avail
literatur
recent
graphenebas
surfac
plasmon
reson
interfac
also
studi
suitabl
applic
spr
sensor
function
surfac
show
sever
advantag
high
surfacetovolum
ratio
adsorpt
organ
biolog
molecul
pi
stack
passiv
oxid
control
number
graphen
layer
strategi
differ
npsbase
approach
also
adopt
last
decad
improv
spr
base
sensor
abba
et
al
collect
last
forefront
tendenc
spr
instrument
advanc
perform
identifi
new
excit
scheme
optic
configur
liquid
handl
microfluid
microsystem
integr
spr
chip
gener
base
glass
poli
dimethylsiloxan
pdm
new
materi
conduct
metal
oxid
zno
znoau
adhes
layer
replac
cr
ti
also
discuss
well
forefront
sprrelat
optoelectron
compon
light
sourc
detector
final
spr
coupl
analyt
techniqu
hyphen
approach
scan
probe
microscopi
electrochemistri
fluoresc
raman
spectroscopi
also
evalu
achiev
higher
sensit
resolut
focus
differ
featur
spr
technolog
physic
principl
instrument
detail
recent
trend
bioreceptor
immobil
approach
assay
design
indirect
direct
simpl
multistep
move
review
applic
strategi
real
case
interest
clinic
diagnost
hormon
small
peptid
analysi
key
area
diagnost
recent
also
antidop
control
endocrin
diseas
diagnosi
may
difficult
requir
directli
assay
hormon
level
blood
eventu
make
indirect
measur
exampl
diabet
mellitu
diagnos
via
measur
blood
glucos
rather
direct
assay
plasma
insulin
interest
exampl
hormon
detect
provid
differ
author
demonstr
abil
spr
provid
interest
solut
also
clinic
area
frasconi
et
al
develop
spr
immunosensor
detect
cortisol
cortison
level
urin
saliva
sampl
eco
chemi
autolab
spr
system
measur
free
cortisol
level
matric
indic
adren
pituitari
gland
disord
dope
analysi
marker
glucocorticoid
illicit
use
urin
sampl
ml
hydrolyz
incub
h
ml
pb
ph
intern
standard
escherichia
coli
saliva
sampl
analyz
without
pretreat
specif
antibodi
immobil
polycarboxylatehydrogelbas
coat
propos
method
result
simpl
inexpens
reproduc
rsd
sensit
detect
limit
less
l
nm
linear
detect
rang
cortisol
cortison
found
good
correl
refer
lcmsm
method
proven
confirm
potenti
util
spr
clinic
pharmacolog
antidop
applic
hormon
monitor
ovarian
function
detect
jiang
et
al
biacor
system
urin
sampl
nonpregn
pregnant
subject
author
develop
inhibit
indirect
immunoassay
steroid
immobil
sensor
surfac
conjug
oligoethylen
glycol
oeg
linker
au
nanoparticleab
conjug
auab
use
enhanc
sensit
spr
assay
detect
limit
pm
urin
dilut
tm
buffer
rapidli
achiev
min
without
complic
sampl
pretreat
good
reproduc
cv
assay
fast
inexpens
compar
tradit
method
base
ria
hplcm
hplc
uv
fluoresc
detect
requir
less
cleanup
step
result
effici
way
monitor
product
rate
urinari
sampl
normal
menstrual
cycl
besid
analysi
low
mw
hormon
spr
sens
also
appli
detect
peptid
hormon
insulin
mw
da
regul
carbohydr
metabol
insulin
sens
serum
greatli
import
clinic
diagnost
followup
patient
affect
variou
type
diabet
also
dope
control
recent
frasconi
et
al
detect
insulin
indirect
immunoassay
human
serum
sampl
healthi
diabet
patient
use
eco
chemi
autolab
spr
system
hydroxyllcpdpfunction
dendrimerencapsul
gnp
coval
bound
amino
coupl
alkanethiol
carboxyl
sammodifi
gold
surfac
insulin
coval
immobil
function
surfac
exploit
aminocoupl
chemistri
immunoassay
fig
innov
surfac
chemistri
reduc
nonspecif
surfac
interact
effect
coupl
local
plasmon
np
surfac
plasmon
lower
dl
pm
ngl
tenfold
dilut
sera
analyz
pm
linear
concentr
rang
radioimmunoassay
refer
method
confirm
reliabl
analyt
devic
inde
biolog
level
insulin
diabet
patient
pm
correspond
rang
pm
dilut
sampl
moreov
sensor
provid
reproduc
result
cv
rang
reusabl
time
high
mw
peptid
hormon
human
pituitari
hormon
recent
detect
spr
particular
lechuga
et
al
develop
bind
inhibit
indirect
immunoassay
spr
sensia
sl
hormon
immobil
sensor
surfac
aminocoupl
work
condit
assay
buffer
regener
solut
optim
detect
first
hgh
growth
hormon
human
serum
sampl
mix
pbst
essenti
develop
normal
growth
also
perform
use
strategi
singl
multianalyt
determin
two
gonadotrop
hormon
urin
serum
sampl
mix
pbst
follicl
stimul
hormon
hfsh
lutein
hormon
hlh
involv
develop
function
reproduct
system
final
detect
hgh
hlh
hfsh
htsh
thyroid
gland
stimul
thyroxin
product
urin
serum
sampl
mix
pbst
use
indirect
immunoassay
coupl
multianalyt
sensor
biosensor
result
sensit
pm
dl
analyt
reusabl
consecut
assay
cycl
specif
analyt
spr
base
immunoassay
result
reproduc
mean
intra
interday
cv
appear
highli
reliabl
tool
endocrin
realtim
daili
monitor
clinic
laboratori
compar
offici
method
ria
ima
elisa
report
segura
mani
area
common
interest
overlap
clinic
analysi
antidop
monitor
methodolog
similar
analysi
human
biolog
matric
detect
analyt
eg
hormon
author
confid
mutual
interact
field
would
abl
bring
mutual
improv
term
technolog
solut
innov
strategi
antidop
code
list
prohibit
substanc
categori
peptid
hormon
growth
factor
relat
substanc
varieti
hormon
releas
factor
found
erythropoiesisstimul
agent
eg
erythropoietin
epo
darbepoetin
depo
hypoxiainduc
factor
hif
stabil
methoxi
polyethylen
glycolepoetin
beta
cera
peginesatid
hematid
chorion
gonadotrophin
cg
lutein
hormon
lh
releas
factor
male
corticotrophin
releas
factor
growth
hormon
gh
releas
factor
insulinlik
growth
addit
sever
growth
factor
also
ban
excel
review
potenti
use
spr
antidop
analysi
provid
segura
group
highlight
convent
analyt
method
detect
human
biotic
dope
agent
ie
recombin
product
may
hardli
distinguish
endogen
exogen
origin
larger
molecul
ie
protein
hormon
innat
structur
complex
heterogen
natur
extrem
low
level
biolog
fluid
made
analyt
procedur
heavili
depend
immunolog
approach
creactiv
protein
crp
kda
import
blood
serum
marker
inflammatori
process
eg
cardiovascular
diseas
cvd
inflammatori
bowel
diseas
current
detect
latexenhanc
turbidimetr
immunoassay
jung
et
al
develop
labelfre
array
system
use
amidelink
al
nhsdextran
biacor
chip
crp
detect
human
sera
afm
studi
found
surfac
suitabl
protein
immobil
normal
epoxidelink
carboxymethyldextran
layer
monoclon
anticrp
antibodi
immobil
onto
surfac
rapid
analysi
crp
perform
nm
concentr
human
sera
dilut
pb
ph
result
show
good
correl
turbidimetri
refer
immunoassay
bini
et
al
immobil
biotinyl
mer
rna
aptam
crp
carboxyl
dextranstreptavidinmodifi
chip
biacor
x
assay
optim
evalu
effect
differ
buffer
effect
ion
interact
aptam
crp
final
specif
aptasensor
put
interf
biomolecul
highest
spr
signal
lowest
detect
limit
nm
suitabl
clinic
applic
record
follow
experiment
condit
serum
dilut
hepe
buffer
ph
mm
concentr
cv
estim
liner
correl
found
within
rang
concentr
experi
serum
solut
show
interf
effect
caus
igg
suggest
need
sampl
pretreat
two
assay
describ
suitabl
clinic
monitor
crp
protein
mgl
adult
serum
achiev
dl
circul
annexin
kda
biomark
relat
variou
diseas
acut
myocardi
infarct
trauma
thrombosi
inflamm
cancer
rapidli
inexpens
detect
human
blood
sampl
dilut
hbsep
et
al
use
biacor
immobil
antibodi
carboxymethyl
dextran
sensor
chip
amino
coupl
found
first
time
level
circul
higher
male
femal
indic
differ
gender
good
linear
observ
good
correl
r
cv
result
prove
labelfre
spr
biosensor
good
altern
labelbas
convent
elisa
immunoassay
advantag
good
sensit
high
reproduc
fast
respons
min
longterm
outcom
cancer
therapi
depend
earli
diagnosi
respons
therapi
import
aspect
cancer
manag
includ
care
monitor
cancer
biomark
physiolog
fluid
et
al
use
homebuilt
spr
instrument
immunodetect
human
serum
alcam
activ
leukocyt
cell
adhes
moleculecd
kd
transmembran
glycoprotein
biomark
pancreat
cancer
typic
concentr
human
serum
antialcam
immobil
via
physic
adsorpt
posit
charg
aminetermin
alkanethiol
sam
surfac
despit
nonspecif
bind
record
suffici
low
dl
achiev
pm
serum
dilut
pb
discrimin
alcam
level
cancer
case
control
sera
good
reproduc
also
confirm
cv
less
direct
detect
without
signal
amplif
show
also
excel
correl
elisa
refer
method
year
ladd
et
al
develop
immunosensor
simultan
specif
detect
alcam
protein
biomark
breast
colorect
carcinoma
specif
antibodi
immobil
aminocoupl
coohoegco
gold
sensor
chip
homebuilt
spri
platform
dl
alcam
pb
buffer
pm
nm
respect
crossreact
record
high
level
nonspecif
adsorpt
found
serum
solut
pb
indic
need
highli
nonfoul
surfac
sensor
applic
piliarik
et
al
combin
highresolut
homebuilt
spri
sensor
highdens
protein
array
lowfoul
background
parallel
detect
protein
cancer
biomark
alcam
hcg
human
chorion
gonadotropin
dilut
blood
plasma
sampl
te
buffer
specif
antibodi
immobil
amino
coupl
lowfoul
chip
surfac
bsa
immobil
carboxyltermin
thiol
biosensor
show
low
nonspecif
protein
adsorpt
less
linear
depend
respons
analyt
concentr
found
hcg
alcam
follow
dl
reach
nm
alcam
nm
hcg
good
reproduc
confirm
cv
less
kazuno
et
al
develop
novel
spr
biosensor
base
method
multisequenti
detect
aal
lectin
estim
glycosyl
haptoglobin
complementari
marker
ovarian
cancer
sera
patient
prostat
cancer
diseas
method
involv
antihaptoglobin
immobil
aminocoupl
sera
dilut
hbsp
buffer
filtrat
final
detect
sugar
chain
lectin
solut
calibr
curv
haptoglobin
obtain
mgml
concentr
rang
multisequenti
analysi
haptoglobin
repres
accur
diagnosist
approach
prostat
cancer
labelfre
spr
biosensor
less
complex
timeconsum
convent
elisa
label
step
enzym
radioact
isotop
fluorescein
requir
gill
et
al
quantifi
kinas
prognost
marker
head
neck
squamou
cell
carcinoma
hnscc
immunosensor
biacor
investig
correl
hnscc
dilut
serum
hbsep
patient
undergo
radiat
therapi
rt
immobil
ab
aminocoupl
sensor
chip
use
western
blot
elisa
refer
method
patient
hnscc
show
increas
level
mgl
nm
compar
control
sampl
valu
duringrt
postrt
treatment
decreas
mgl
nm
mgl
nm
respect
show
reduct
attribut
clinic
tumor
regress
rt
result
confirm
suitabl
serum
marker
hnscc
coupl
spr
sens
offer
higher
sensit
tradit
antibodybas
method
elisa
western
blot
et
al
develop
spr
biosensor
dispersionless
microfluid
homebuilt
detect
solubl
vascular
endotheli
growth
factor
receptor
biomark
abnorm
produc
cancer
cell
myelodysplast
syndrom
md
vegfa
homodimer
glycoprotein
coval
immobil
sensor
surfac
amino
coupl
allow
detect
human
blood
pb
dl
nm
good
reproduc
approach
suggest
model
futur
protein
multiarray
md
diagnosi
base
interact
assay
result
less
sensit
convent
detect
base
elisa
capabl
detect
respect
healthi
individu
md
patient
innov
approach
biomark
detect
present
liu
et
al
vegf
releas
solut
live
ovarian
cell
ie
cancer
cell
fig
antivegf
ab
immobil
protein
gcoat
chip
surfac
analyt
produc
flow
chamber
pdm
directli
monitor
linear
respons
mgl
vegf
concentr
rang
reproduc
interassay
rsd
less
assess
pb
buffer
cell
viabil
demonstr
vivo
microenviron
vegf
signal
pathway
mimick
quantif
vegf
releas
cell
carcinoma
cell
number
accur
predict
show
suitabl
innov
strategi
realtim
monitor
biomark
express
live
cell
underlin
vegf
also
target
molecul
antidop
analysi
present
wada
list
prohibit
substanc
battaglia
et
al
develop
fiberopt
spr
biosensor
simultan
detect
three
cytokin
relat
chronic
wound
heal
tumor
necrosi
factorr
tnfr
reach
detect
limit
hb
buffer
spike
cell
cultur
medium
ccm
specif
antibodi
immobil
spr
fiberopt
aminocoupl
nonspecif
bind
cell
cultur
medium
protein
observ
biosensor
surfac
sensor
emerg
reliabl
devic
multipl
specif
biomark
detect
sinc
tnfr
concentr
normal
heal
wound
respect
chronic
wound
moreov
level
detect
normal
heal
wound
ngml
detect
heal
wound
cardiac
marker
protein
releas
injur
myocardi
cell
bloodstream
cardiovascular
diseas
cvd
use
better
diagnos
cvd
condit
promptli
effici
particular
brain
natriuret
peptid
bnp
kda
hormon
secret
mainli
cardiac
ventricl
blood
frequent
monitor
marker
cardiac
failur
teramura
et
al
develop
sandwichtyp
immunosensor
bnp
detect
donor
plasma
pretreat
use
nanobead
signal
amplif
fig
primari
antibnp
ab
immobil
coohsam
chip
surfac
amino
coupl
homebuilt
spr
instrument
sandwich
assay
perform
secondari
biotinyl
antibodi
immunoaffin
interact
bnp
final
streptavidinconjug
nanobead
nm
diamet
ad
signal
amplif
enhanc
sensit
lower
dl
nm
ngl
pm
linear
observ
ngl
bnp
concentr
rang
confirm
suitabl
immunosensor
clinic
necess
sinc
normal
level
bnp
plasma
ngl
increas
approxim
acut
chronic
cardiac
failur
sensit
compar
commerci
avail
refer
assay
bnp
ria
chemiluminesc
reaction
ngl
addit
indirect
immunoassay
coupl
portabl
spr
instrument
develop
microfluid
also
report
bnp
detect
human
serum
pb
sampl
incub
acetylcholin
esteraselabel
antibodi
introduc
microchannel
devic
freebnp
conjug
bound
bnp
previous
immobil
surfac
aminocoupl
acetylthiocholin
ad
substrat
hydrolyz
acetylcholin
esteras
thiol
compound
thiocholin
produc
coval
bound
thin
gold
layer
locat
downstream
microchannel
gener
spr
angl
shift
monitor
analyt
signal
concentr
rang
ngl
examin
trace
level
analyt
fg
detect
min
cv
five
measur
ngl
bnp
although
valu
high
compar
commerci
immunosens
system
author
consid
rsd
accept
clinic
diagnosi
sinc
bnp
concentr
significantli
increas
heart
failur
patient
mention
two
proteic
myocardi
infarct
biomark
myoglobin
mg
cardiac
troponin
ctni
quantifi
biolog
level
undilut
serum
without
sampl
pretreat
use
fiberopt
spr
immunosensor
jobinyvon
spex
spectromet
specif
antibodi
immobil
via
amino
coupl
sam
minim
nonspecif
signal
serum
protein
dl
pm
mg
pm
ctni
well
threshold
limit
detect
myocardi
infarct
diseas
approxim
mg
ctni
good
reproduc
cv
linear
correspond
signal
concentr
also
assess
analyt
liu
et
al
design
spr
biosensor
high
antifoul
abil
detect
cardiac
marker
troponin
dpb
buffer
antitroponin
antibodi
immobil
aminocoupl
chip
surfac
navi
spr
coat
homogen
sam
oligo
ethylen
glycol
oeg
termin
alkanethiol
mercaptohexadecano
acid
mhda
system
show
interest
high
antifoul
properti
high
resist
nonspecif
adsorpt
hsa
high
affin
specif
detect
troponin
good
linear
correl
r
dl
nm
also
confirm
biosens
play
crucial
role
analysi
autoantibodi
human
serum
realtim
monitor
autoimmun
diseas
increas
number
research
avail
literatur
schlichtig
et
al
recent
review
differ
biosensorbas
approach
field
author
also
emphas
main
advantag
spr
monitor
bind
realtim
multiplex
analys
autoantibodi
use
microarray
eg
spri
detect
pathogen
antidsdna
ab
sera
patient
affect
lupu
erythematosu
sle
report
buhl
et
al
antigen
construct
form
follow
synthet
oligonucleotid
cho
coupl
biotinyl
human
transferrin
use
aceton
hydrazon
sanh
coval
linker
hybrid
complementari
antistrand
ligat
human
recombin
dsdna
fragment
bp
length
conjug
final
immobil
gold
surfac
coat
carboxymethyldextran
function
streptavidin
dilut
sera
diluent
sle
patient
healthi
donor
analyz
spr
biosensor
system
biacor
x
result
author
confirm
sle
patient
specif
sensit
compar
posit
result
farr
ria
assay
specif
sensit
moreov
good
reproduc
confirm
intraassay
imprecis
daytoday
variat
make
spr
biosensor
realli
suit
antidsdna
ab
detect
sle
diseas
addit
devic
provid
inform
bind
kinet
affin
specif
autoantibodi
group
also
studi
interact
dsdna
antidsdna
autoantibodi
sle
sera
patient
biacor
x
dsdna
immobil
strategi
previous
describ
character
kinet
offrat
function
affin
avid
three
antidsdna
mab
confirm
import
kinet
properti
explan
behavior
mab
tradit
method
farr
ria
elisa
metzger
et
al
develop
biosensor
diagnosi
antiphospholipid
syndrom
ap
discrimin
diseaserelev
autoantibodi
crossreact
antibodi
develop
infect
human
coval
link
chip
surfac
coat
nalkanethiol
sam
biacor
x
sera
hb
ap
patient
patient
sle
syphili
parvoviru
healthi
donor
analyz
result
compar
elisa
test
signific
antibodi
bind
signal
ru
record
sampl
healthi
individu
patient
infect
wherea
respons
level
rang
ru
record
posit
ap
patient
sera
correl
coeffici
refer
elisa
test
sprbase
assay
also
reproduc
sinc
signific
loss
activ
record
measur
cycl
patient
sera
later
studi
et
al
use
instrument
setup
prove
correl
affin
patient
sera
hb
antigen
prepar
manufactur
origin
purif
method
studi
explain
interassay
differ
elisa
confirm
one
common
prepar
would
improv
interassay
compar
year
author
also
demonstr
employ
domainspecif
peptid
would
offer
diagnost
advantag
primari
autoantibodi
screen
ap
discrimin
sera
ap
patient
sera
healthi
patient
schlichtig
et
al
detect
antiphospholipid
antibodi
apl
serolog
indic
diseas
immunosensor
develop
biacor
x
platform
particular
detect
cardiolipin
antibodi
acl
sera
hepe
healthi
donor
ap
patient
cardiolipin
immobil
amino
coupl
activ
edcnh
acid
samcoat
chip
surfac
bind
agab
monitor
assay
confirm
ap
diagnost
specif
equal
standard
elisa
method
use
routin
diagnost
show
sensit
elisa
versu
moreov
chip
regener
measur
excel
intrachip
reproduc
rsd
chiptochip
reproduc
rsd
rutger
et
al
report
kinet
analysi
antigbm
autoantibodi
sera
nephrit
patient
perform
biacor
instrument
purifi
bovin
collagen
iv
control
iv
ag
immobil
onto
carboxymethyl
dextran
hydrogel
surfac
edcnh
activ
autoantibodi
patient
sera
bound
iv
wherea
bind
record
iv
control
estim
dissoci
associ
constant
demonstr
high
affin
abag
high
veloc
associ
slow
dissoci
explain
rapid
cours
diseas
well
resist
therapi
persist
ab
glomerular
aggreg
could
gener
potenti
incess
inflamm
alaedini
et
al
detect
autoantibodi
monosialotetrahexosyl
gangliosid
relat
acut
chronic
motor
neuropathi
ag
control
gangliosid
absorb
methyl
dextran
layer
chip
discrimin
patient
sera
healthi
control
possibl
sensit
specif
compar
classic
elisa
test
antiglutam
acid
decarboxylas
gad
autoantibodi
detect
indic
type
diabet
mellitu
develop
lee
et
al
biacor
ratio
thiol
first
optim
coval
bind
biotinyl
gad
via
streptavidin
immobil
nhsedc
activ
antigad
ab
analyz
hb
buffer
within
concentr
rang
interfer
biomolecul
bsa
control
found
neglig
carlsson
et
al
detect
insulin
autoantibodi
iaa
serum
sampl
individu
high
risk
develop
type
diabet
design
indirect
competit
immunoassay
bypass
nonspecif
adsorpt
matrix
protein
could
mask
analyt
signal
insulin
immobil
chip
biacor
x
activ
nhsedc
sensor
calibr
iaa
uml
sera
deriv
pool
nondiabet
serum
spike
pool
high
iaaposit
serum
obtain
ident
matrix
composit
excel
assay
perform
report
sinc
analysi
time
reduc
day
min
sensit
compar
offer
ria
cutoff
posit
uml
healthi
swedish
children
parallel
immunoassay
spr
microarray
imag
ibi
technolog
use
lokat
et
al
detect
anticitrullin
protein
antibodi
acpa
sera
patient
pbst
affect
rheumatoid
arthriti
ra
carboxyl
xantec
hc
nm
sensor
chip
activ
nhsedc
two
differ
linear
citrullin
peptid
cita
citb
immobil
surfac
arga
argb
arginin
instead
citrullin
spot
correspond
control
peptid
interact
citrullin
peptid
serum
autoantibodi
ra
patient
control
monitor
experiment
dl
pm
although
sensit
slightli
lower
refer
elisa
test
spr
system
present
advantag
autom
surfac
regener
repetit
incub
mm
make
test
realli
suitabl
daili
routin
clinic
control
three
year
later
similar
approach
appli
van
beer
et
al
ibisispr
imag
analysi
autoantibodi
peptid
fraction
ra
patient
dilut
sera
pbst
peptid
obtain
citrullin
human
fibrinogen
immobil
dextran
hydrogel
surfac
activ
nhsedc
three
major
citrullin
epitop
identifi
multiarray
enabl
simultan
detect
autoantibodiespeptid
interact
signific
reduct
analysi
time
result
less
timeconsum
accur
refer
elisa
screen
method
spr
imagingbas
sens
also
use
scarano
et
al
antibovin
igg
detect
untreat
human
serum
milk
sinc
high
level
antibodi
relat
type
diabet
serum
children
bovin
igg
immobil
microarraymod
spri
lab
horiba
amino
coupl
muacoat
gold
chip
surfac
nonspecif
adsorpt
matrix
effect
evalu
dedic
softwar
aim
optim
guid
autom
select
bestreact
spot
fig
antibovin
igg
detect
rang
concentr
mgl
real
dilut
matric
serum
milk
hepe
buffer
standard
addit
method
good
linear
respons
r
good
reproduc
among
experi
cv
dl
mgl
nm
achiev
serum
milk
equal
good
perform
evalu
r
cv
dl
mgl
nm
assay
open
new
horizon
detect
protein
complex
real
matric
spribas
biosens
sinc
clinic
data
eg
serum
display
antibovin
igg
valu
mgl
median
valu
mgl
carcinoembryon
antigen
cea
autoantibodi
specif
cea
biomark
associ
colorect
gastric
pancreat
cancer
monitor
cancer
human
serum
sampl
ladd
et
al
homebuilt
spr
instrument
cea
immobil
carboxyl
gold
surfac
aminocoupl
autoantibodi
detect
sandwich
assay
ad
secondari
antibodi
goat
antihuman
igghrp
conjug
sera
dilut
pbsa
buffer
test
cea
autoantibodi
concentr
around
mgl
result
dilut
autoantibodi
distinguish
cancer
sera
sampl
healthi
sampl
use
elisa
refer
assay
find
could
use
diagnost
criterion
earli
cancer
detect
well
diagnosi
diseas
progress
studi
chromosom
anomali
spr
real
sampl
deal
detect
point
mutat
singl
nucleotid
polymorph
snp
point
mutat
occur
frequenc
mutat
may
remark
involv
clinic
diagnosi
occur
specif
code
region
chromosomerel
common
diseas
particular
spr
use
tool
detect
point
mutat
relat
tumor
suppressor
gene
eg
kra
cancer
diseas
hereditari
diseas
tumor
suppressor
gene
mostli
mutat
gene
presenc
human
cancer
reason
one
studi
gene
cancer
research
also
assaysbas
spr
transduct
system
jiang
et
al
detect
point
mutat
dna
sprbase
sens
use
portabl
instrument
texa
instrument
spreeta
synthet
thiolat
oligonucleotid
mer
immobil
gold
chip
surfac
captur
probe
snp
analysi
real
dna
sampl
extract
amplifi
concentr
normal
wildtyp
jurkat
mutat
molt
cell
line
biosensor
distinguish
sequenc
differ
one
base
snp
posit
signal
lower
molt
min
low
nonspecif
respons
abil
regener
sensor
time
find
coupl
good
reproduc
cv
prove
method
potenti
routin
clinic
analysi
year
wilson
et
al
report
use
mut
natur
protein
abl
recogn
select
mismatch
sequenc
detect
snp
synthet
oligonucleotid
analogu
instrument
prior
inject
ssb
singl
strand
bind
protein
prevent
nonspecif
interact
mut
thiolat
ssdna
immobil
sensor
sensor
regener
time
least
make
whole
approach
realli
inexpens
detect
clinic
relev
mutat
sipova
et
al
develop
sandwichlik
assay
detect
snp
codon
short
mer
synthet
analogu
fourchannel
spr
biosensor
develop
institut
photon
electron
pragu
immobil
thiolat
probe
hybrid
target
son
complex
investig
polymorph
site
secondari
hybrid
enhanc
good
sensit
pm
good
specif
achiev
detect
begin
nanotech
era
metal
nobl
nanoparticl
assum
central
role
develop
sensit
assay
point
mutat
discrimin
yao
et
al
develop
method
base
sandwichlik
assay
coupl
nanoparticl
detect
snp
gene
excis
plasmid
bp
homebuilt
spr
thiolat
oligonucleotid
link
gnp
signal
enhanc
snp
discrimin
f
target
concentr
sampl
method
adequ
reproduc
rsd
specif
thank
carboxyl
dextran
film
prevent
nonspecif
adsorpt
nucleotidecap
gnp
therefor
sprbase
test
attract
analyt
concentr
low
sampl
avail
limit
anoth
origin
approach
base
np
coupl
spr
imag
dna
sensor
spr
imag
gwc
technolog
develop
corn
group
high
sensit
detect
snp
clinic
interest
particular
picomolar
detect
snp
gene
associ
breast
cancer
reach
nonamplifi
human
dna
sampl
measur
surfac
enzymat
ligat
reaction
enhanc
gold
nanoparticl
coupl
spri
thiolat
dna
microarray
snp
genotyp
attract
could
multiplex
simultan
analysi
multipl
snp
instrument
use
spoto
cowork
enhanc
snp
detect
employ
streptavinco
gnp
link
biotinyl
oligonucleotid
pna
probe
immobil
gold
surfac
previous
function
dithiobi
nsuccinimidylpropion
dtp
femtomolar
sensit
reach
synthet
dna
target
pb
buffer
make
strategi
suitabl
detect
dna
sampl
without
pcr
amplif
inde
year
later
approach
fig
appli
snp
discrimin
human
globin
gene
involv
sever
type
thalassemia
directli
nonamplifi
genet
materi
isol
leucocyt
peripher
blood
attomolar
concentr
bypass
pcr
step
mention
introduct
label
np
demonstr
use
improv
analyt
perform
increas
sensit
lower
dl
strategi
genom
dna
directli
detect
without
pcr
amplif
step
side
synthesi
np
time
reagentconsum
interest
exampl
combin
use
artifici
dna
spr
abl
enhanc
sensit
diagnost
snp
investig
eventu
report
literatur
feriotto
et
al
report
first
applic
pna
spr
human
hereditari
mutat
particular
author
detect
snp
cf
gene
associ
cystic
fibrosi
biacor
spr
pcramplifi
sampl
biotinyl
immobil
sensor
surfac
streptavidinbiotin
chemistri
pna
probe
hybrid
immobil
pcr
product
recognit
polymorph
report
result
suggest
spr
easi
fast
min
automat
platform
detect
mutat
realtim
monitor
hybrid
unlik
method
base
gel
electrophoresi
andor
dotspot
analysi
three
year
later
corradini
et
al
use
biacor
discrimin
snp
cf
gene
chiral
chain
modifi
pna
base
dlisin
improv
recognit
abil
compar
simpl
pna
approach
review
snp
discrimin
perform
without
employ
enhanc
factor
ie
protein
nanoparticl
artifici
dna
speed
assay
lower
cost
recent
ermini
et
al
develop
sensit
labelfre
dna
sensor
specif
detect
nonamplifi
gene
fragment
extract
human
lymphocyt
spri
lab
platform
horiba
scientif
key
gene
pharmacogenom
mani
snp
implic
common
set
problem
alter
drug
level
suscept
diseas
eg
inflammatori
bowel
diseas
parkinson
diseas
refractori
seizur
cell
recoveri
human
immunodefici
viru
therapi
sandwich
assay
base
optim
sampl
pretreat
fragment
denatur
coupl
ration
design
select
perform
probe
particular
thiolat
captur
probe
immobil
sensor
surfac
hybrid
target
gene
fragment
secondari
probe
hybrid
confirm
select
captur
year
assay
describ
optim
secondari
probe
label
length
success
appli
detect
snp
gene
relat
suscept
mani
diseas
colorect
breast
renal
cancer
snp
discrimin
perform
genom
dna
extract
human
lymphocyt
randomli
enrich
mgl
fm
whole
genom
amplif
wga
measur
reproduc
cv
sensor
reusabl
time
microrna
mirna
import
gene
regulatori
nucleic
acid
mer
human
affect
transcript
posttranscript
regul
gene
express
mirna
also
key
role
marker
seriou
diseas
ie
cancer
heart
diseas
diabet
nervou
system
diseas
liver
diseas
includ
high
femtomolar
low
nanomolar
rang
concentr
human
blood
howev
mirna
yet
mention
literatur
coupl
spr
clinic
routin
analysi
review
academ
research
detect
abund
mirna
hepatocyt
achiev
futur
key
role
clinic
diagnosi
predict
marker
viral
alcohol
chemicalinduc
liver
diseas
fast
simpl
assay
recent
describ
zhang
et
al
detect
extract
human
breast
tumor
cell
detect
base
simpl
hybrid
sandwichlik
assay
hybrid
fulli
complementari
thiolat
dna
probe
immobil
sensor
surfac
use
biacor
x
secondari
biotinyl
dna
probe
link
streptavidin
hybrid
target
enhanc
sensit
lower
detect
limit
pm
addit
assay
pcrfree
show
good
reproduc
cv
corn
cowork
describ
innov
approach
detect
mirna
extract
mous
liver
tissu
base
thiolat
lna
microarray
immobil
gold
chip
surfac
spr
imag
gwc
technolog
simultan
detect
mous
liver
tissu
achiev
fm
enhanc
spri
transduct
poli
enzym
chemistri
au
nanoparticl
fig
despit
high
sensit
specif
method
requir
elabor
multistep
protocol
portabl
na
sensor
base
sprcd
coupler
dispens
special
diffract
grate
develop
sipova
et
al
nonamplifi
extract
mous
liver
tissu
captur
thiolat
dna
immobil
sensor
surfac
specif
antibodi
recogn
dnarnaform
hybrid
enhanc
respons
allow
detect
less
min
pm
result
good
agreement
obtain
use
qpcr
although
two
describ
assay
develop
detect
mirna
mous
liver
repres
excel
model
system
improv
analyt
perform
eg
dl
lower
suitabl
next
applic
detect
human
mirna
sampl
sinc
current
method
detect
pathogen
expens
time
consum
involv
culturebas
techniqu
spr
platform
also
employ
survey
bacteria
eg
escherichia
coli
environment
monitor
clinic
diagnost
detect
bacteri
genet
materi
biomark
kai
et
al
develop
method
rapid
detect
verotoxinproduc
escherichia
coli
isol
stool
amplifi
pcr
use
te
sampl
buffer
biotinyl
pna
bioreceptor
immobil
streptavidinco
sensorchip
sa
biacor
good
correl
found
posit
result
pcr
cfu
per
g
stool
sampl
patient
healthi
carrier
sensor
reusabl
time
regener
wash
solut
mm
naoh
wang
et
al
detect
simultan
four
pathogen
microorgan
pseudomona
aeruginosa
staphylococcu
aureu
clostridium
tetani
clostridium
perfringen
dna
extract
four
pathogen
amplifi
simultan
univers
primer
rna
hybrid
sprbase
multichannel
sensor
specif
dna
probe
immobil
thiol
chemistri
assay
specif
fast
dl
pm
c
tetani
addit
good
linear
depend
r
record
signal
pcr
product
concentr
nm
although
dna
extract
commerci
bacteri
strain
human
matric
studi
clearli
show
potenti
multi
array
high
analyt
product
clinic
diagnost
min
four
specif
interact
final
zhang
et
al
develop
labelfre
sensit
method
detect
inva
gene
extract
bacteri
cultur
salmonella
amplifi
pcr
biotinyl
ssdna
probe
immobil
streptavidinco
dextran
chip
surfac
biacor
x
sensor
previous
calibr
synthet
target
dna
good
linear
nm
detect
limit
nm
assess
detect
salmonella
possibl
low
cfuml
within
h
excel
regener
sensor
surfac
cycl
bindingregener
allow
sensor
reus
cost
reduct
sprbase
detect
antibodi
viral
pathogen
medic
diagnost
previous
review
homola
particular
review
focus
antibodi
detect
hepat
g
c
hepat
b
herp
simplex
viru
type
type
epsteinbarr
viru
varicellazolt
viru
human
respiratori
syncyti
viru
adenoviru
antibodi
herp
simplex
viru
type
type
detect
biacor
x
dilut
human
serum
hb
buffer
biotinyl
peptid
correspond
segment
nterminu
glycoprotein
b
gb
immobil
antigen
chip
coat
streptavidin
spr
biosensor
discrimin
specif
abag
bind
better
convent
refer
method
elisa
evalu
lowavid
background
reactiv
record
frequent
human
sera
abad
et
al
detect
antiadenovir
antibodi
dilut
sera
patient
hepe
buffer
dose
adenoviralbas
gene
therapi
vector
dextran
aminocoupl
chemistri
use
immobil
intact
viru
chip
surfac
biacor
assay
use
design
effici
dose
schedul
autom
requir
less
analysi
setup
time
refer
elisa
method
antibodi
detect
hepat
g
patient
serum
perform
rojo
et
al
synthet
peptid
antigen
immobil
biacor
via
dextran
aminocoupl
chemistri
find
good
correl
elisa
refer
test
chemistri
immobil
use
mcgill
et
al
detect
human
respiratori
syncyti
viru
rsv
dilut
serum
hb
buffer
biacor
antibodi
viru
glycoprotein
f
g
coval
immobil
dextran
discrimin
antigen
differ
two
viru
genotyp
f
gglycoprotein
indirect
assay
describ
chung
et
al
detect
antibodi
human
hepat
b
viru
hhbv
dilut
patient
serum
pb
hhbv
antigen
immobil
via
aminocoupl
spreeta
surfac
platform
dl
nm
nm
amplif
avidinbiotinyl
secondari
antibodi
achiev
similar
result
refer
elisa
kit
diagnosi
hepat
regnault
et
al
develop
assay
detect
antiprotein
antibodi
express
varicellazolt
viral
diseas
dilut
plasma
hb
buffer
infect
patient
dextran
layer
employ
immobil
protein
via
amin
coupl
surfac
biacor
x
high
bind
ru
observ
serum
patient
wherea
low
signal
rang
ru
record
plasma
healthi
donor
et
al
describ
detect
antibodi
epsteinbarr
viru
antiena
dilut
human
serum
pb
buffer
homebuilt
spr
sensor
platform
base
wavelength
divis
multiplex
wdm
synthet
peptid
bioreceptor
immobil
surfac
via
hydrophob
electrostat
interact
antiebna
antibodi
detect
pm
interchip
rsd
sensor
respons
estim
within
rang
wherea
intrachip
rsd
found
lower
show
good
reproduc
situat
summari
analyt
perform
compar
convent
peptidebas
immunoassay
elisa
kumbhat
et
al
develop
immunosensor
detect
dengu
viru
specif
igm
antibodi
infect
patient
serum
differ
dilut
pb
use
autolab
model
springl
dengu
antigenbsa
conjug
immobil
bioreceptor
via
aminocoupl
gold
sens
surfac
function
mercaptoundecano
sam
addit
sensor
regener
pepsin
solut
glycinhcl
buffer
ph
result
compar
obtain
macelisa
nilsson
et
al
design
inhibit
assay
indirect
quantif
hemagglutinin
ha
glycoprotein
capsid
season
influenza
virus
recombin
ha
proteic
ag
b
immobil
via
aminocoupl
dextran
matrix
biacor
chip
specif
antibodi
mix
serum
solut
viru
antigen
fig
detect
limit
mgl
method
result
precis
intracv
faster
h
singleradi
immunediffus
srid
refer
method
intracv
analysi
time
h
park
et
al
report
preliminari
studi
pb
buffer
detect
sar
coronavir
envelop
protein
scvme
diagnosi
sever
acut
respiratori
syndrom
sar
scvme
anchor
gold
chip
surfac
spri
kmac
gold
bind
protein
gbp
select
sensit
detect
antiscvm
antibodi
perform
dl
min
afm
spr
imag
analys
confirm
antiscvmespecif
captur
antigen
domain
appropri
orient
wang
et
al
employ
highresolut
spr
microscopi
sprm
labelfre
imag
detect
singl
virus
particl
influenza
hcmv
pb
buffer
mass
dl
antiinfluenza
antibodi
coval
immobil
pegpegcooh
coat
gold
chip
surfac
via
aminocoupl
studi
demonstr
suitabl
method
assess
mass
bind
activ
individu
viral
particl
section
detect
pathogen
bacteria
microorgan
review
focus
immunolog
assay
direct
pathogen
antipathogen
antibodi
detect
salmonella
frequent
gastrointestin
pathogen
involv
mani
diseas
diarrhea
gastrointestin
inflamm
lifethreaten
typhoid
fever
wide
report
literatur
coupl
sprbase
sens
sprbase
sandwich
immunoassay
develop
pb
buffer
muzumdar
et
al
serotyp
salmonella
b
c
polyclon
antibodi
salmonella
immobil
spr
chip
plasmon
biosensoren
ag
captur
salmonella
bacteri
cell
probe
antigenspecif
antibodi
serotyp
method
rapid
quantit
detect
limit
cellml
spr
immunosensor
provid
comprehens
quantit
inform
convent
slide
agglutin
test
sat
recent
gupta
et
al
design
immunosensor
salmonella
typhi
antibodi
detect
pb
buffer
patient
sera
salmonella
typhi
antigen
immobil
acid
modifi
gold
surfac
chip
electrochem
surfac
plasmon
reson
system
autolab
esprit
discrimin
posit
widal
posit
neg
sera
widal
neg
achiev
less
min
experiment
dl
respect
dilut
mab
dilut
salmonella
typhi
antibodi
good
reproduc
measur
record
cv
boer
et
al
detect
glycanspecif
serum
antibodi
biomark
exogen
pathogen
human
sera
infect
parasit
schistosoma
mansoni
sera
dilut
pbst
glycan
sampl
print
epoxideactiv
chip
biacor
flexchip
differ
serum
antibodi
profil
infect
sera
control
sera
reveal
realtim
without
fluoresc
label
isi
web
knowledg
report
almost
public
relat
spr
sens
analyz
distribut
topic
technolog
impact
significantli
clinic
chemistri
howev
studi
demonstr
proof
principl
recent
report
applic
real
matric
appear
review
consid
panel
analyt
interest
clinic
diagnost
also
focus
emerg
technolog
innov
coupl
spr
nanoparticl
microfluid
new
chip
design
improv
analyt
perform
detect
hormon
relat
endocrin
disord
protein
biomark
relat
variou
condit
inflamm
state
trauma
specif
cancer
cardiac
diseas
discuss
case
studi
antibodi
detect
also
report
relat
diagnosi
infect
immun
system
diseas
addit
review
nucleic
acid
sens
detect
genet
disord
also
recogn
specif
sequenc
pathogen
viru
bacteria
detect
mirna
emerg
biomark
final
discuss
immunosens
approach
pathogen
detect
select
privileg
studi
conduct
real
matric
blood
serum
urin
except
analyt
strategi
appear
especi
origin
innov
develop
innov
chip
chemistri
antifoul
strategi
guarante
reduc
nonspecif
bind
essenti
complex
biolog
fluid
analysi
amin
coupl
allow
coval
immobil
receptor
ensur
repeat
measur
chip
simpl
dissoci
complex
chaotrop
reagent
interestingli
sampl
pretreat
reduc
minimum
dilut
sometim
short
heat
filtrat
summari
sprbase
biosensor
offer
analyt
perform
sensit
dl
reproduc
compar
convent
method
employ
clinic
analysi
electrophoresi
chromatographi
elisa
ria
etc
addit
ensur
realtim
monitor
labelfre
solut
parallel
analysi
spri
high
throughput
littl
sampl
pretreat
fast
respons
cheap
reason
believ
near
futur
spr
emerg
effici
power
altern
tool
daili
routin
clinic
analysi
open
also
new
horizon
futur
develop
person
medicin
point
care
diagnost
